Wikipedia:WikiProject Chemicals/Chembox validation/VerifiedDataSandbox and W-18 (drug): Difference between pages
(Difference between pages)
Content deleted Content added
Saving copy of the {{drugbox}} taken from revid 448092781 of page 1-(4-Nitrophenylethyl)piperidylidene-2-(4-chlorophenyl)sulfonamide for the Chem/Drugbox validation project (updated: ''). |
Michael7604 (talk | contribs) recategorized from Nitrobenzenes to Nitrobenzene derivatives |
||
Line 1: | Line 1: | ||
{{Short description|Chemical compound}} |
|||
{{ambox | text = This page contains a copy of the infobox ({{tl|drugbox}}) taken from revid [{{fullurl:1-(4-Nitrophenylethyl)piperidylidene-2-(4-chlorophenyl)sulfonamide|oldid=448092781}} 448092781] of page [[1-(4-Nitrophenylethyl)piperidylidene-2-(4-chlorophenyl)sulfonamide]] with values updated to verified values.}} |
|||
{{Drugbox |
{{Drugbox |
||
| Verifiedfields = changed |
|||
⚫ | |||
| Watchedfields = changed |
|||
⚫ | |||
⚫ | |||
| image = 1-(4-Nitrophenylethyl)piperidylidene-2-(4-chlorophenyl)sulfonamide.png |
|||
⚫ | |||
⚫ | |||
| image = Z-W-18.svg |
|||
⚫ | |||
<!--Clinical data--> |
<!--Clinical data--> |
||
| tradename = |
| tradename = |
||
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X --> |
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X --> |
||
| pregnancy_US = <!-- A / B / C / D / X --> |
| pregnancy_US = <!-- A / B / C / D / X --> |
||
| pregnancy_category = |
| pregnancy_category = |
||
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 --> |
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 --> |
||
| legal_CA = |
| legal_CA = |
||
| legal_UK = |
| legal_UK = |
||
| legal_US = |
| legal_US = |
||
| legal_status = |
| legal_status = Illegal in Sweden and Canada |
||
| routes_of_administration = |
| routes_of_administration = |
||
<!--Pharmacokinetic data--> |
<!--Pharmacokinetic data--> |
||
| bioavailability = |
| bioavailability = |
||
| protein_bound = |
| protein_bound = |
||
| metabolism = |
| metabolism = |
||
| elimination_half-life = |
| elimination_half-life = |
||
| excretion = |
| excretion = |
||
<!--Identifiers--> |
<!--Identifiers--> |
||
| CAS_number_Ref = {{cascite|changed|??}} |
|||
| CAS_number = |
| CAS_number = 93101-02-1 |
||
⚫ | |||
| UNII_Ref = {{fdacite|correct|FDA}} |
|||
⚫ | |||
| |
| UNII = 04WOYJF7QH |
||
⚫ | |||
⚫ | |||
| PubChem = 57501076 |
|||
| DrugBank_Ref = {{drugbankcite|correct|drugbank}} |
| DrugBank_Ref = {{drugbankcite|correct|drugbank}} |
||
| DrugBank = |
| DrugBank = |
||
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} |
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} |
||
| ChemSpiderID = |
| ChemSpiderID = 28537256 |
||
<!--Chemical data--> |
<!--Chemical data--> |
||
| C=19 | H=20 | Cl=1 | N=3 | O=4 | S=1 |
| C=19 | H=20 | Cl=1 | N=3 | O=4 | S=1 |
||
| smiles = C1CCN(/C(=N\S(=O)(=O)C2=CC=C(C=C2)Cl)/C1)CCC3=CC=C(C=C3)[N+](=O)[O-] |
|||
| molecular_weight = 421.91 g/mol |
|||
| smiles = c3cc(N(=O)=O)ccc3CCN1CCCCC1=NS(=O)(=O)c3ccc(Cl)cc3 |
|||
| InChI = 1/C19H20ClN3O4S/c20-16-6-10-18(11-7-16)28(26,27)21-19-3-1-2-13-22(19)14-12-15-4-8-17(9-5-15)23(24)25/h4-11H,1-3,12-14H2/b21-19+ |
|||
| InChIKey = BKRSVROQVRTSND-XUTLUUPIBV |
|||
| StdInChI_Ref = {{stdinchicite|correct|chemspider}} |
| StdInChI_Ref = {{stdinchicite|correct|chemspider}} |
||
| StdInChI = 1S/C19H20ClN3O4S/c20-16-6-10-18(11-7-16)28(26,27)21-19-3-1-2-13-22(19)14-12-15-4-8-17(9-5-15)23(24)25/h4-11H,1-3,12-14H2/b21-19 |
| StdInChI = 1S/C19H20ClN3O4S/c20-16-6-10-18(11-7-16)28(26,27)21-19-3-1-2-13-22(19)14-12-15-4-8-17(9-5-15)23(24)25/h4-11H,1-3,12-14H2/b21-19- |
||
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} |
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} |
||
| StdInChIKey = BKRSVROQVRTSND- |
| StdInChIKey = BKRSVROQVRTSND-VZCXRCSSSA-N |
||
| synonyms = |
| synonyms = |
||
| melting_point = 157 |
| melting_point = 157 |
||
| melting_high = 158 |
| melting_high = 158 |
||
}} |
}} |
||
'''W-18''' is a compound in a series of 32 substances (named W-1 to W-32) that were first synthesized in academic research on [[analgesic]] [[drug discovery]] in the 1980s and appeared as a [[designer drug]] in the 2010s. |
|||
W-18 was invented at the [[University of Alberta]] by a lab working on [[analgesic]] [[drug discovery]] in the 1980s, and preliminary studies in animals showed it had pain-killing activity in mice.<ref name=forbes>{{cite web|url=https://www.forbes.com/sites/davidkroll/2016/04/30/w-18-the-high-potency-research-chemical-making-news-what-it-is-and-what-it-isnt/#2b1ef5562354|title=W-18, The High-Potency Research Chemical Making News: What It Is And What It Isn't|date=30 April 2016| vauthors = Kroll D |work=Forbes}}</ref><ref>{{cite web|url=http://www.cbc.ca/news/canada/edmonton/street-drug-w-18-is-highly-lethal-and-still-legal-1.3546094|title=Street drug W-18 is highly lethal, and still legal|publisher=CBC News|date=21 April 2016|access-date=20 April 2016| vauthors = Warnica M }}</ref> |
|||
The chemical was detected in connection with recreational drug use as substitute for other [[controlled substance]]s in Europe in 2013,<ref name=Gazette>{{cite journal| vauthors = Gonçalves J |title=Notice to interested parties — Proposal regarding the scheduling of W-18 under the Controlled Drugs and Substances Act and its regulations|journal=Canada Gazette|date=13 February 2016|volume=150|issue=7|url=http://gazette.gc.ca/rp-pr/p1/2016/2016-02-13/html/notice-avis-eng.php#nl3|access-date=19 February 2016|publisher=Government of Canada}}</ref> and in the United States.<ref name=macleans/> In Canada, [[Alberta Law Enforcement Response Teams]] (ALERT) seized four kilograms of W-18 in a drug bust in [[Edmonton]] in December 2015<ref name="cbc-news">{{cite news|url=http://www.cbc.ca/news/canada/edmonton/illicit-drug-w-18-is-100-times-stronger-than-fentanyl-police-warn-1.3544662|title=Illicit drug W-18 is 100 times stronger than fentanyl, police warn|work=CBC News|date=20 April 2016|access-date=20 April 2016}}</ref> and W-18 was also detected by [[Health Canada]] in at least three of 110 [[fentanyl]] tablets seized from a [[Calgary]] home in August 2015.<ref>{{cite web|url=https://www.vice.com/en_ca/read/everything-we-know-so-far-about-w-18-the-drug-thats-100-times-more-powerful-than-fentanyl|title=Everything We Know So Far About W-18, the Drug That's 100 Times More Powerful Than Fentanyl|publisher=Vice Media|work=Vice.com|date=1 February 2016|access-date=20 April 2016| vauthors = Elkin A }}</ref><ref name=macleans>{{cite web| vauthors = Markusoff J |title=A toxic drug, more powerful than fentanyl, hits the streets in Alberta|url=http://www.macleans.ca/?dpsfa_article=a-toxic-drug-more-powerful-than-fentanyl-hits-the-streets-in-alberta|website=macleans.ca|publisher=Maclean's|access-date=19 February 2016}}</ref> |
|||
W-18 was commonly reported to be an [[opioid]] in the popular press in the 2010s, which was later revealed not to be correct.<ref name="calgaryherald">{{cite web | url=https://calgaryherald.com/news/local-news/health-canada-statements-on-w-18-misleading-potentially-wrong-experts-warn | title=Health Canada statements on W-18 misleading, potentially wrong, experts warn | publisher=Postmedia Network Inc. | work=Calgary Herald | date=1 June 2016 | access-date=22 June 2016 | vauthors = Southwick R }}</ref><ref>{{cite web | url=https://news.vice.com/article/canadas-ban-on-ultra-potent-drug-w-18-could-make-things-worse | title=Canada's Ban on Ultra-Potent Drug W-18 Could Make Things Worse | publisher=Vice | date=2 June 2016 | vauthors = Browne R }}</ref><ref name="Roth">{{cite journal | vauthors = Huang XP, Che T, Mangano TJ, Le Rouzic V, Pan YX, Majumdar S, Cameron MD, Baumann MH, Pasternak GW, Roth BL | display-authors = 6 | title = Fentanyl-related designer drugs W-18 and W-15 lack appreciable opioid activity in vitro and in vivo | journal = JCI Insight | volume = 2 | issue = 22 | date = November 2017 | pmid = 29202454 | pmc = 5752382 | doi = 10.1172/jci.insight.97222 | author10-link = Bryan Roth }}</ref> W-18 was found to obtain weak activity at both [[sigma receptor]]s and the [[translocator protein]] (peripheral benzodiazepine receptor).<ref name="Roth"/> It also inhibits the [[hERG]] potassium channel with micromolar affinity, which could potentially cause cardiac arrhythmia at high doses.<ref>{{Cite journal| vauthors = Huang XP, Che T, Mangano TJ, Le Rouzic V, Pan YX, Majumdar S, Cameron M, Bauman M, Pasternak GW, Roth BL | display-authors = 6 |date=2016-07-24|title=Pharmacology of W-18 and W-15 | journal = bioRxiv |language=en|pages=065623|doi=10.1101/065623|doi-access=free}}</ref> |
|||
* In Sweden, W-18 was made illegal in January 2016.<ref>{{cite web | url=https://www.folkhalsomyndigheten.se/nyheter-och-press/nyhetsarkiv/2015/november/31-nya-amnen-kan-klassas-som-narkotika-eller-halsofarlig-vara/ | title=31 nya ämnen kan klassas som narkotika eller hälsofarlig vara | publisher=Folkhälsomyndigheten | language=Swedish | date=November 2015}}</ref> |
|||
* In Canada, W-18 and its analogues were made Schedule I controlled substances.<ref>{{cite journal | url=http://www.gazette.gc.ca/rp-pr/p2/2016/2016-06-01/html/sor-dors106-eng.php | title=Regulations Amending the Food and Drug Regulations (Parts G and J — Lefetamine, AH-7921, MT-45 and W-18) | first = Denis | last = Arsenault | name-list-style = vanc | journal=Canada Gazette | date=1 June 2016 | volume=150 | issue=11 | publisher=Government of Canada}}</ref> Possession without legal authority can result in maximum 7 years imprisonment. Further, [[Health Canada]] amended the ''Food and Drug Regulations'' in May, 2016 to classify W-18 as a restricted drug. Only those with a law enforcement agency, person with an exemption permit or institutions with Minister's authorization may possess the drug. |
|||
== See also == |
|||
* [[Ro5-4864]] |
|||
== References == |
|||
{{Reflist}} |
|||
{{Ion channel modulators}} |
|||
{{Sigma receptor modulators}} |
|||
{{Translocator protein modulators}} |
|||
{{DEFAULTSORT:W-18}} |
|||
[[Category:Chlorobenzene derivatives]] |
|||
[[Category:Nitrobenzene derivatives]] |
|||
[[Category:Piperidines]] |
|||
[[Category:Sigma receptor ligands]] |
|||
[[Category:Sulfonamides]] |
|||
[[Category:TSPO ligands]] |